• Naringenin Attenuates ER Stress–Driven Insulin Resistance in

  2026-07-31

  This study demonstrates that naringenin counteracts hepatitis C virus (HCV)-induced insulin resistance by suppressing endoplasmic reticulum (ER) stress and the IRE1α/XBP1 pathway in liver models. The findings clarify how ER stress links HCV infection to metabolic dysfunction and highlight molecular targets for future therapeutic research.

• Cabazitaxel (XRP6258): Technical Protocols for Resistant Mod

  2026-07-31

  Cabazitaxel (XRP6258) is a semi-synthetic taxane optimized for disrupting microtubule dynamics in taxane-resistant tumor models, especially those with P-glycoprotein-mediated chemoresistance. It is unsuitable for water-based assays and long-term solution storage, but provides reliable results in DMSO- or ethanol-based workflows when handled per technical guidelines.

• Talin1’s Role in Piezo1–YAP Axis and Endothelial Inflammatio

  2026-07-30

  This study uncovers how Talin1 modulates the Piezo1–YAP axis to drive endothelial inflammation and atherosclerosis. The findings provide mechanistic detail on calcium-dependent signaling in vascular disease and suggest new targets for anti-inflammatory intervention.

• Glucocorticoid Receptor Control of Hippocampal CYP in Phenyt

  2026-07-30

  This study uncovers a glucocorticoid receptor-dependent mechanism by which pregnenolone 16α-carbonitrile (PCN) suppresses hippocampal cytochrome P450 (CYP) expression, thereby attenuating phenytoin-induced neurotoxicity in mice. These findings clarify brain-specific regulation of CYP enzymes and suggest glucocorticoids as promising candidates for protecting neuronal health during antiepileptic therapy.

• Phosphatase Inhibitor Cocktail 2 (100X): Reliable Phosphoryl

  2026-07-29

  This article addresses real-world laboratory challenges in preserving protein phosphorylation during cell viability and signaling assays. Drawing on published evidence and validated best practices, we show how Phosphatase Inhibitor Cocktail 2 (100X in ddH2O), SKU K1013, ensures reproducible, high-sensitivity results across diverse workflows.

• IPR-803 (SKU BA8331): Reliable uPAR Inhibitor for Tumor Rese

  2026-07-29

  This article addresses core laboratory challenges in cancer research by demonstrating how IPR-803 (SKU BA8331), a validated urokinase receptor inhibitor, delivers reproducible and data-backed solutions for cell invasion and metastasis assays. Researchers will find scenario-driven guidance on experimental design, protocol optimization, and product selection, supported by robust literature and direct links to APExBIO’s product page.

• Applied Workflows with Recombinant Human Epidermal Growth Fa

  2026-07-28

  Harnessing recombinant human EGF enables precision control of cell migration, proliferation, and mucosal repair in both fundamental and translational research. This article offers evidence-driven protocols, troubleshooting strategies, and integration of recent mechanistic findings to boost experimental reliability and impact.

• 2X Taq PCR Master Mix: Streamlined PCR for Genotyping & Clon

  2026-07-28

  Accelerate and simplify your DNA amplification with the 2X Taq PCR Master Mix (with dye)—an optimized, ready-to-use PCR reagent for direct gel loading, robust genotyping, and efficient TA cloning. Experience workflow enhancements and troubleshooting insights that empower high-throughput molecular biology applications.

• Decoding 5-bromo-N-(4,5-dihydro-1H-imidazol-2-yl)quinoxalin-

  2026-07-27

  Explore the scientific foundations of 5-bromo-N-(4,5-dihydro-1H-imidazol-2-yl)quinoxalin-6-amine as a selective α2-adrenergic receptor agonist. This article offers advanced mechanistic analysis for researchers investigating immune rejection modulation and the latest breakthroughs in osteosarcoma recurrence models.

• EdU Flow Cytometry Assay Kits (Cy5): Precision S-Phase Detec

  2026-07-27

  EdU Flow Cytometry Assay Kits (Cy5) harness click chemistry for rapid, high-sensitivity S-phase DNA synthesis detection—streamlining cell proliferation workflows and enabling advanced multiplexing without harsh denaturation. This workflow-centric guide spotlights practical protocol choices, troubleshooting, and translational impact for wound healing and oncology research.

• Silybin A: Silymarin’s Precision Tool for Liver Disease Rese

  2026-07-26

  Silybin A, the bioactive core of Silymarin, empowers researchers with reproducible, high-fidelity modeling of liver protection and metabolic modulation. APExBIO’s rigorously characterized Silybin A unlocks advanced workflows, troubleshooting strategies, and reliable assay performance for hepatoprotective and anti-inflammatory investigations.

• Moesin as a Biomarker of Endothelial Injury in Sepsis: Mecha

  2026-07-25

  Chen et al. (2021) identify moesin (MSN) as a novel biomarker that strongly reflects the severity of endothelial injury in sepsis, linking its elevation with clinical and experimental measures of vascular dysfunction. This work advances understanding of MSN’s mechanistic role in endothelial barrier disruption and offers a foundation for future diagnostic and therapeutic strategies.

• SB 203580: Selective p38 MAPK Inhibitor for Pathway Dissecti

  2026-07-24

  SB 203580 (4-[4-(4-fluorophenyl)-2-(4-methylsulfinylphenyl)-1H-imidazol-5-yl]pyridine) is a potent, selective inhibitor of the p38 MAPK signaling pathway, widely used to dissect kinase-driven inflammation and neuroprotection. Its nanomolar affinity and established in vitro benchmarks enable precise mechanistic studies in disease models. APExBIO supplies SB 203580 (SKU A8254) for research applications.

• Mifepristone (RU486): Applied Protocols for Cancer & Reprodu

  2026-07-24

  Mifepristone (RU486) is a gold-standard cell-permeable progesterone receptor antagonist, enabling advanced studies in cancer biology and reproductive science. This article delivers practical workflows, troubleshooting guidance, and comparative insights to maximize the impact of RU486 in experimental settings, with direct translation from recent AR heterogeneity research.

• Norovirus Exploits NINJ1 for Selective NS1 Secretion and Hos

  2026-07-23

  Song et al. reveal that murine norovirus leverages the host membrane protein NINJ1 to selectively secrete its NS1 protein, distinguishing this from the bulk release of cellular DAMPs during cell death. This work uncovers a novel, selective secretion mechanism, with broad implications for understanding viral immune evasion and the regulation of programmed cell death.

11442 records 1/763 page Next 12345 下5页 Last page